# Gala Pharmaceutical Inc.

Gala Pharmaceutical Inc. is a company headquartered in Irvine, CA, United States.

## Company overview

- **Legal name:** Gala Pharmaceutical Inc.
- **Former names in filing history:** Gala Pharmaceuticals Inc. (2018-02-28 to 2018-07-20); Gala Global Inc. (2011-03-11 to 2018-01-05)
- **Classification:** Company
- **Industry (SIC):** 2300 — Apparel & Other Finishd Prods of Fabrics & Similar Matl
- **Headquarters:** Irvine, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** November 30
- **SEC CIK:** 0001513403

## About

Gala Pharmaceutical Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001513403, and its reported industry is Apparel & Other Finishd Prods of Fabrics & Similar Matl. In 10-K filed on 2019-04-15, it reported annual revenue of USD 4,675; net income of USD -1,858,877; total assets of USD 262,158 for the fiscal period ended 2018-11-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-11-30)

- **Revenue:** $4,675 (USD 4,675)
- **Net income:** -$1.9M (USD -1,858,877)
- **Total assets:** $262,158 (USD 262,158)
- **Cash and equivalents:** $116,198 (USD 116,198)
- **Operating cash flow:** -$631,890 (USD -631,890)

### FY2017 (period ended 2017-11-30)

- **Net income:** -$2.0M (USD -1,981,856)
- **Total assets:** $107,976 (USD 107,976)
- **Cash and equivalents:** $7,767 (USD 7,767)
- **Operating cash flow:** -$323,695 (USD -323,695)

### FY2016 (period ended 2016-11-30)

- **Revenue:** $0 (USD 0)
- **Net income:** -$170,176 (USD -170,176)
- **Total assets:** $13,082 (USD 13,082)
- **Cash and equivalents:** $10,841 (USD 10,841)
- **Operating cash flow:** -$70,503 (USD -70,503)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-11-30)

- **Net income:** -$679,466 (USD -679,466)
- **Total assets:** $7,422 (USD 7,422)
- **Cash and equivalents:** $1,804 (USD 1,804)
- **Operating cash flow:** -$126,679 (USD -126,679)

## Recent SEC filings

- Form 8-K — filed 2020-05-04 — period 2020-04-29 — FORM 8-K
- Form 8-K — filed 2019-10-21 — period 2019-10-16 — FORM 8-K
- Form 10-Q — filed 2019-07-23 — period 2019-05-31 — QUARTERLY REPORT
- Form 10-Q — filed 2019-04-30 — period 2019-02-28 — FORM 10-Q
- Form 10-K — filed 2019-04-15 — period 2018-11-30 — FORM 10-K
- Form 8-K — filed 2019-03-20 — period 2019-03-19 — FORM 8-K
- Form 8-K — filed 2019-01-14 — period 2019-01-10 — FORM 8-K
- Form 8-K — filed 2019-01-03 — period 2019-01-02 — FORM 8-K
- Form 8-K — filed 2018-11-30 — period 2018-11-30 — FORM 8-K
- Form 10-Q — filed 2018-10-26 — period 2018-08-31 — FORM 10-Q
- Form 8-K — filed 2018-10-03 — period 2018-09-26 — FORM 8-K
- Form 10-Q — filed 2018-08-01 — period 2018-05-31 — FORM 10-Q

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/gala-pharmaceutical-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology